Figure 1.

Figure 2.

Figure 3.

Figure 4.

The pre-treatment endometriotic lesion measurements
| Control (n = 10) (mean ± sd) | bLF (n = 10) (mean ± sd) | Progesteron (n = 10) (mean ± sd) | Mixed (n = 10) (mean ± sd) | P | |
|---|---|---|---|---|---|
| Total volume (mm3) | 0.02319 ± 0.02837 | 0.0643 ± 0.14557 | 0.01694 ± 0.01387 | 0.03822 ± 0.03076 | 0.358 |
| Total ellipsoid volume (mm3) | 0.01181 ± 0.0149 | 0.03078 ± 0.07577 | 0.00802 ± 0.00688 | 0.019 ± 0.01447 | 0.112 |
| Total adhesion score | 1.875 ± 1.3562 | 1.33333 ± 1.22474 | 1 ± 1 | 1.55556 ± 1.01379 | 0.480 |
The post-treatment PGR, TNF-α, and IL-1β expression in endometriotic tissue
| Control (n = 10) (mean ± sd) | bLF (n = 10) (mean ± sd) | Progesteron (n = 10) (mean ± sd) | Mixed (n = 10) (mean ± sd) | P | |
|---|---|---|---|---|---|
| TNF-α | 3 ± 0 | 1.67 ± 0.52 | 2 ± 0 | 1 ± 0 | 0.001** |
| IL-1β | 2.83 ± 0.41 | 2 ± 0 | 2.17 ± 0.41 | 1.17 ± 0.41 | 0.001** |
| PGR | 2.83 ± 0.41 | 2.17 ± 0.41 | 2.17 ± 0.41 | 1 ± 0 | 0.001** |
The differences of pre- and post-treatment measurements
| Control (n = 10) (mean ± sd) | bLF (n = 10) (mean ± sd) | Progesteron (n = 10) (mean ± sd) | Mixed (n = 10) (mean ± sd) | P | |
|---|---|---|---|---|---|
| Total volume (mm3) | −0.01 ± 0.04 | −0.05 ± 0.14 | −0.01 ± 0.02 | −0.03 ± 0.03 | 0.653 |
| Total ellipsoid volume (mm3) | −0.01 ± 0.02 | −0.02 ± 0.08 | −0.01 ± 0.01 | −0.01 ± 0.02 | 0.413 |
| Total adhesion score | −0.13 ± 2.64 | 0.56 ± 2.01 | 0.78 ± 1.48 | 0.56 ± 1.01 | 0.890 |
The post-treatment TAS and TOS values
| Control (n = 10) (mean ± sd) | bLF (n = 10) (mean ± sd) | Progesteron (n = 10) (mean ± sd) | Mixed (n = 10) (mean ± sd) | P | |
|---|---|---|---|---|---|
| TAS (mmol trolox equiv./kg wet weight) | 30.73 ± 16.07 | 23.14 ± 7.63 | 22.75 ± 9.66 | 21.5 ± 2.11 | 0.623 |
| TOS (µmol H2O2 equiv./gprot) | 81.45 ± 16.67 | 76.12 ± 17.9 | 82.39 ± 27.12 | 85.54 ± 11.69 | 0.318 |
The post treatment blood progesterone and LF values
| Control (n = 10) (mean ± sd) | bLF (n = 10) (mean ± sd) | Progesteron (n = 10) (mean ± sd) | Mixed (n = 10) (mean ± sd) | P | |
|---|---|---|---|---|---|
| Progesterone (ng/mL) | 2.84 ± 1.94 | 3.83 ± 3.29 | 2.98 ± 1.82 | 3.19 ± 1.28 | 0.0627 |
| LF (µ/mL) | 35.54 ± 3.83 | 37.01 ± 5.8 | 27.84 ± 1.42 | 38.56 ± 5.75 | 0.001** |
The post-treatment endometriotic lesion measurements
| Control (n = 10) (mean ± sd) | bLF (n = 10) (mean ± sd) | Progesteron (n = 10) (mean ± sd) | Mixed (n = 10) (mean ± sd) | P | |
|---|---|---|---|---|---|
| Total volume (mm3) | 0.01 ± 0.03 | 0.02 ± 0.01 | 0 ± 0 | 0.01 ± 0.01 | 0.225 |
| Total ellipsoid volume (mm3) | 0.01 ± 0.01 | 0.01 ± 0.01 | 0 ± 0 | 0.01 ± 0.01 | 0.265 |
| Total adhesion score | 1.75 ± 1.39 | 1.89 ± 1.05 | 1.78 ± 1.2 | 2.11 ± 0.93 | 0.959 |